Effect of hypertonic salin7% plus in treatment of Pseudomonas aeruginosa in the lung of the patient with cystic fibrosis disease.
Phase 3
Recruiting
- Conditions
- cystic fibrosis.Cystic fibrosis
- Registration Number
- IRCT20201017049055N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
positive sputum culture with Pseudomonas aeruginosa
The patient has the ability to excrete sputum
The disease is in a stable condition (not in exacerbation)
Forced expiratory volume(FEV1) is above 50%.
have cystic fibrosis disease.
Exclusion Criteria
have hyper reactive airway disease.
O2 saturation below 94%, in air room or when treated with oxygen.
changes in cystic fibrosis drug over the past 4 weeks.
have untreated reflux disease.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method